Description:Dehydro ivabradine is a chemical compound that serves as a derivative of ivabradine, primarily known for its role in cardiovascular pharmacology. It is characterized by its ability to selectively inhibit the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, particularly HCN4, which plays a crucial role in regulating heart rate. This compound is typically utilized in research settings to explore its potential therapeutic effects on conditions such as heart failure and angina. Structurally, dehydro ivabradine features a modified chemical framework compared to its parent compound, which may influence its pharmacokinetic properties and biological activity. The compound is often studied for its efficacy, safety profile, and potential side effects, contributing to the understanding of heart rate modulation. As with many pharmaceutical compounds, its solubility, stability, and interaction with biological systems are key characteristics that determine its applicability in clinical settings. Overall, dehydro ivabradine represents an important area of investigation in the development of heart rate-controlling medications.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.